... Pharmaceuticals and Sanofi for violating Repatha patents. In October 2014, Amgen sued Paris-based Sanofi and Tarrytown, N.Y.-based Regeneron for violating patents for Repatha after Sanofi and Regeneron co-developed PSK9 inhibitor Praluent to treat ...
http://ift.tt/29CAIp1
No comments:
Post a Comment